The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.
about
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.Treating rheumatoid arthritis to target: recommendations of an international task force.Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire.American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.Risk of congenital anomalies in pregnant users of statin drugs.Hypercholesterolemia: its impact on ischemia-reperfusion injury.Should cholesterol-lowering medications be available in Canada without a prescription?Isocoumarin-based inhibitors of pancreatic cholesterol esterase.Utility of genetic determinants of lipids and cardiovascular events in assessing risk.Squalene monooxygenase - a target for hypercholesterolemic therapy.Rheumatoid arthritis disease measurement: a new old idea.Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model.Statins and primary prevention: is all the evidence in?Rosuvastatin-induced rhabdomyolysis probably via CYP2C9 saturation.Targeted versus global approaches to the management of hypercholesterolaemia.Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.Differences in predicted cardiovascular risk in Sinhalese and Tamils in Sri Lanka compared with Sri Lankans in Norway.
P2860
Q33347904-2366ACFD-C061-4E72-B14C-7B0139C2EABEQ34462557-DFD96A62-ACF1-44BB-8F9D-15AD8B63526BQ35740447-226DD921-6620-490B-9FB0-9061D24C7076Q35772358-ED0A2121-A14A-4392-8D42-EE5F83E1EF7EQ36102633-2CC4090F-C156-4533-A17D-D0774D7DE593Q36314857-DEB22E0D-FE0C-4283-8814-0ABE4B2F6123Q36755379-FF8F2047-74BA-4811-9BCF-CEA1053FA02FQ36776071-4F30850E-D0EC-4F81-A81A-AB6365B6BC5EQ37842125-51FB2040-0592-429E-8676-5FA4EC855920Q37952270-9192BBD8-D0AB-4073-A74E-9570FABE79CFQ38065766-73312CA9-51D1-47D1-8EE3-9F2BA46A4CE7Q38906383-30119828-C78F-43F1-B4D5-B5E671C201F6Q43179430-A6B8493A-898A-43DA-92F2-59462A9E0DAAQ43486922-B49B71DB-CC1A-49C9-862A-5CB4E9474DF4Q44983323-00EA2A16-E196-4FAA-A3B2-AF0091B0F6A9Q46731522-A9B2D7D7-9AF5-494E-9970-EE28C20B9B55Q54585490-13348026-283F-41F6-BCE3-BB8FF6A802B7
P2860
The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The epidemiologic basis for po ...... on of coronary artery disease.
@ast
The epidemiologic basis for po ...... on of coronary artery disease.
@en
type
label
The epidemiologic basis for po ...... on of coronary artery disease.
@ast
The epidemiologic basis for po ...... on of coronary artery disease.
@en
prefLabel
The epidemiologic basis for po ...... on of coronary artery disease.
@ast
The epidemiologic basis for po ...... on of coronary artery disease.
@en
P1476
The epidemiologic basis for po ...... on of coronary artery disease.
@en
P2093
Thomas A Pearson
P356
10.1016/J.AMJCARD.2004.07.046
P407
P577
2004-11-01T00:00:00Z